CRB-701

· Corbus Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CRB-701, covering 2026-01-08 to 2026-01-08. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors [Phase 1, Phase 2]